2018 / 06

DOI: 10.24075/brsmu.2018.074

ORIGINAL RESEARCH

Identification of BRCA1/2 mutations in breast cancer patients by next-generation sequencing

Stetsenko IF1, Krasnenko AYu1,2, Stanoevich US3, Mescheryakov AA4, Vorotnikov IK4, Druzhilovskaya OS1, Belova VA1, Churov AV1,5
About authors

1 Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia

2 Genotek Inc., Moscow

3 Russian Research Center of Roentgenradiology of the Ministry of Healthcare of the Russian Federation, Moscow

4 Blokhin National Medical Research Center of Oncology, Moscow

5 Institute of Biology, Karelian Research Center of the Russian Academy of Sciences (IB KarRC RAS), Petrozavodsk

Correspondence should be addressed: Alexey V. Churov
Pushkinskaya 11, Petrozavodsk,185910; ur.xednay@uoruhca

About paper

Funding: this work was supported by the Ministry of Education and Science of the Russian Federation (Project ID RFMEFI60716X0152).

Received: 2018-12-03 Accepted: 2018-12-14 Published online: 2018-12-25
|
  1. Bejsebaev EN. Sovremennye sravnitel'nye aspekty jepidemiologii raka molochnoj zhelezy. Vestnik KazNMU. 2014; (1): 78–83.
  2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; (136): E359–86.
  3. Tao Z, Shi A, Lu C, Song T, Zhang Z, Zhao J. Breast Cancer: Epidemiology and Etiology. Cell Biochem Biophys. 2015; (72): 333–8.
  4. Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and Mortality and Epidemiology of Breast Cancer in the World. Asian Pac J Cancer Prev. 2016; (17): 43–6.
  5. Bykova AV, Vorotnikov IK, Vishnevskaja JaV, Denchik DA, Ljubchenko LN. Rol' mutacii genov BRCA 1 i BRCA 2 v vozniknovenii raka molochnoj zhelezy u muzhchin. Opuholi zhenskoj reproduktivnoj sistemy. 2011; (1): 29–31.
  6. Giuliano AE, Connolly JL, Edge SB, Mittendorf EA, Rugo HS, Solin LJ et al. Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017; 67 (4): 290–303.
  7. Cukanov KJu, Krasnenko AJu, Korostin DO, Churov AV, Stecenko IF, Plotnikov NA i dr. Rak molochnoj zhelezy: analiz spektra somaticheskih drajvernyh mutacij s primeneniem vysokoproizvoditel'nogo sekvenirovanija. Vestnik RGMU. 2017; (6): 52–8.
  8. Cukanov KJu, Krasnenko AJu, Plahina DA, Korostin DO, Churov AV, Druzhilovskaja O. S. i dr. Bioinformaticheskij protokol dlja obrabotki NGS-dannyh i identifikacii mutacij v solidnyh opuholjah cheloveka. Biomedicinskaja himija. 2017; 63 (5): 413–7.
  9. Krassowski M, Paczkowska M, Cullion K, Huang T, Dzneladze I, Ouellette BFF et al. ActiveDriverDB: human disease mutations and genome variation in post-translational modification sites of proteins. Nucleic Acids Res. 2018; 46: D901–D910.
  10. Zhou X, Edmonson MN, Wilkinson MR, Patel A, Wu G, Liu Y et al. Exploring genomic alteration in pediatric cancer using protein paint. Nat Genet. 2015; (48): 4–6.
  11. Forbes SA, Beare D, Bindal N, Bamford S, Ward S, Cole CG et al. COSMIC: High-Resolution Cancer Genetics Using the Catalogue of Somatic Mutations in Cancer. Curr Protoc Hum Genet. 2016; (91): 10.11.1–10.11.37.